Short title
Short title. This Act may be cited as the Right to Try Act. (Source: P.A. 99-270, eff. 1-1-16.)
Illinois · statute · 410 ILCS 649 · 8 active provisions
Short title. This Act may be cited as the Right to Try Act. (Source: P.A. 99-270, eff. 1-1-16.)
Findings. The General Assembly finds that the process of approval for investigational drugs, biological products, and devices in the United States often takes many years, and a patient with a terminal illness does not have the luxury of waiting until such drug, product, or device receives final approval from the United…
Definitions. For the purposes of this Act: "Accident and health insurer" has the meaning given to that term in Section 126.2 of the Illinois Insurance Code. "Eligible patient" means a person who: (1) has a terminal illness; (2) has considered all other treatment options approved by the United States Food and Drug Admin…
Availability of drugs, biological products, and devices. (a) A manufacturer of an investigational drug, biological product, or device may make available such drug, product, or device to eligible patients. Nothing in this Act shall be construed to require a manufacturer to make available any drug, product, or device. (b…
Insurance coverage. An accident and health insurer may choose to provide coverage for the cost of an investigational drug, biological product, or device. Nothing in this Act shall be construed to require an accident and health insurer to provide coverage for the cost of any investigational drug, biological product, or…
Penalty. Any official, employee, or agent of the State who blocks or attempts to block access by an eligible patient to an investigational drug, biological product, or device shall be guilty of a misdemeanor, punishable by a fine not to exceed $1,500. (Source: P.A. 99-270, eff. 1-1-16.)
(Amendatory provisions; text omitted). (Source: P.A. 99-270, eff. 1-1-16; text omitted.)
(Amendatory provisions; text omitted). (Source: P.A. 99-270, eff. 1-1-16; text omitted.)